24 October 2025
Primary Health Properties PLC
("PHP", the "Group" or the "Company")
2025 Annual General Meeting - Voting Results Update Statement
At the Company's Annual General Meeting ("AGM") held on 7 May 2025, the total vote received in favour of Resolution 6 (the re-election of Harry Hyman) was 79.28%. This was 0.72% below the 80% UK Corporate Governance Code (the "Code") approval threshold for the resolution.
Given more than 20% of votes were cast against this resolution, the Company is providing an update on the views received from shareholders and actions taken, as required by provision 4 of the Code.
Since the AGM, the Company has - as a consequence of its recently completed, successful offer to acquire Assura plc - had a unique opportunity to engage with its shareholders. Those conversations have demonstrated to the Company the firm confidence which its investors have in its leadership with Harry Hyman as Non-executive Chair and Mark Davies as Chief Executive Officer, and in the configuration of its Board as a whole.
The Company continues to be committed to maintaining the highest standards of corporate governance. Accordingly, it will continue regular and meaningful engagement with its investors, always mindful of its compliance with Code, and all other, requirements, balanced with ensuring the Company has the optimal mix of skills and experience to deliver its strategy against a backdrop of the dynamic evolution of government health policy and plans for primary care.
The Board would like to thank all the shareholders that have engaged with the Company for their continuing feedback and support. In line with its normal practice, the Board will continue to engage with shareholders and their representative bodies and will provide further updates as appropriate.
Legal Entity Identifier: 213800Y5CJHXOATK7X11
For further information please contact:
Primary Health Properties PLC
Toby Newman, Company Secretary & Chief Legal Officer +44(0) 772 9047 959
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.